3.19 (-%)
As of Oct 31, 2024
Source:
Pds Biotechnology Corp is a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer and infectious disease immunotherapies based on our proprietary Versamune , Versamune plus IL-12 and Infectimune™ T cell activating technology platforms.
| Country | United States |
| Headquarters | florham park, new jersey |
| Phone Number | 800-208-3343 |
| Industry | manufacturing |
| CEO | Frank Bedu-Addo |
| Website | www.pdsbiotech.com |